FORECASTING HIV PREVALENCE AMONG INDIVIDUALS AGED 15-49 YEARS IN CUBA USING HOLT’S DOUBLE EXPONENTIAL SMOOTHING MODEL

UNDP (2014). BUILDING, IMPROVING AND

SUSTAINING RESPONSES TO HIV LEARNING

FROM CUBA’S SUCCESS, pp. 1-2

Edson Delatorre and Gonzalo Bello (2013).

Phylodynamics of the HIV-1 Epidemic in Cuba.

PLoS ONE 8:9, e72448.

Carlos Aragonés-López, Jorge Pérez-Ávila,

Mary C. Smith Fawzi and Arachu Castro

(2012). Quality of Life of People with

HIV/AIDS Receiving Antiretroviral Therapy in

Cuba: A Cross-Sectional Study of the National

Population. American Journal of Public Health

:5, 884-892

Aragonés C, Sánchez L, Campos JR and Pérez

J (2011). Antiretroviral therapy adherence in

persons with HIV/AIDS in Cuba. MEDICC Rev.

(2):17–23. Available from:

http://www.medicc.org/medicc

review/pdf.php?lang=en&id=192

Pérez L, Álvarez LP, Carmona R, Aragonés C,

Delgado E and Thomson MM (2007).

Genotypic resistance to antiretroviral drugs in

patients infected with several HIV type 1

genetic forms in Cuba. AIDS Res Hum

Retroviruses. 23(3):407–14. Available from:

https://www.liebertpub.com/doi/pdf/10.1089/

aid.2006.0155

Alemán-Campos et al (2018). HIV-1

Antiretroviral Resistance in Cuba, 2009–2014,

MEDICC Review, July 2018, Vol 20, No. 3